1. Home
  2. BWIN vs ATAI Comparison

BWIN vs ATAI Comparison

Compare BWIN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Baldwin Insurance Group Inc.

BWIN

The Baldwin Insurance Group Inc.

HOLD

Current Price

$29.21

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo ATAI Life Sciences N.V.

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$7.21

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWIN
ATAI
Founded
2011
2018
Country
United States
United States
Employees
5020
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
BWIN
ATAI
Price
$29.21
$7.21
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$30.43
$15.88
AVG Volume (30 Days)
1.2M
17.7M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,089,000.00
Revenue This Year
$36.36
N/A
Revenue Next Year
$10.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$15.88
$3.27
52 Week High
$34.79
$7.22

Technical Indicators

Market Signals
Indicator
BWIN
ATAI
Relative Strength Index (RSI) 59.06 72.28
Support Level $25.80 $3.89
Resistance Level N/A N/A
Average True Range (ATR) 1.32 0.05
MACD 0.01 -0.06
Stochastic Oscillator 73.23 75.00

Price Performance

Historical Comparison
BWIN
ATAI

About BWIN The Baldwin Insurance Group Inc.

The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: